Significant Ownership of QVT Financial LP

Large-stake filing summary: Recent SEC Schedule 13D/G filings for QVT Financial LP focus on large-stake beneficial ownership disclosures and amendments.
Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager signature: /s/ Meg Eisner - Authorized Signatory
Manager location: New York, NY

Follow Filing Activity

Follow QVT Financial LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

CIK context first

Continue from QVT Financial LP

Broader feeds

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ALLT	Allot Ltd.	Ordinary Shares, par value ILS 0.10 per share	10%	$47,739,592	+$14,208,464	5,062,523	+42%	QVT Financial LP	18 Nov 2025
WHWK	Aadi Bioscience, Inc.	Common stock, $0.0001 par value per share	9.4%	$3,563,101		2,313,702		QVT Financial LP	31 Dec 2024
TRML	Tourmaline Bio, Inc.	Common Stock, $0.0001 par value per share	8.4%	$34,883,832	+$11,029,988	2,154,653	+46%	QVT Financial LP	30 Jun 2025
CMTL	Comtech Telecommunications Corp.	Common stock, $0.10 par value per share	5.7%	$5,625,630		1,694,467		QVT Financial LP	31 Mar 2026
ROIV	Roivant Sciences Ltd.	Common shares, par value $0.0000000341740141 per share	4.3%	$319,084,556	-$395,435,884	29,381,635	-55%	QVT Financial LP	30 Jun 2025

Sym	Target	Class	Ownership	Change	Current shares	Change	Value	Reporting name	Form	Report period	Filing date

Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.